Home › Funds › Opaleye Management Inc. › INBX
Opaleye Management Inc. position in INBX
INHIBRX BIOSCIENCES INC COM · Health Care
Opaleye Management Inc. reported holding 20,291 shares of INBX (INHIBRX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 0.17% of its reported portfolio and ranking #47 among its reported holdings. Opaleye Management Inc. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s INBX position evolved
Opaleye Management Inc. first disclosed a stake in INBX in Q2 2026 at 20,291 shares (US$1.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 20.29K | $1.92M | New |
About INBX and 13F data
INBX (INHIBRX BIOSCIENCES INC COM) is a Health Care company. 44 other funds we track also report a position in INBX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$123.0M), Sanofi (US$109.7M), Schonfeld Strategic Advisors LLC (US$66.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INBX
- PERCEPTIVE ADVISORS LLC 1.30M sh · $122.96M · Q2 2026
- Sanofi 1.16M sh · $109.71M · Q2 2026
- Schonfeld Strategic Advisors LLC 697.59K sh · $66.10M · Q2 2026
- PFM Health Sciences, LP 308.38K sh · $29.22M · Q2 2026
- Sofinnova Investments, Inc. 303.10K sh · $28.72M · Q2 2026
- Parkman Healthcare Partners LLC 256.95K sh · $24.35M · Q2 2026
- First Turn Management, LLC 164.78K sh · $15.61M · Q2 2026
- Western Standard LLC 47.00K sh · $4.45M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held INBX?
Opaleye Management Inc. has disclosed INBX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Opaleye Management Inc.'s current position in INBX?
As of Q2 2026, Opaleye Management Inc. holds 20.29K shares of INBX (INHIBRX BIOSCIENCES INC COM), valued at $1.92M, representing 0.17% of its reported portfolio and ranking #47.
Has Opaleye Management Inc. been buying or selling INBX?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. newly opened its position in INBX.
Which other funds hold INBX?
Other major institutional holders of INBX include PERCEPTIVE ADVISORS LLC, Sanofi, Schonfeld Strategic Advisors LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.